Expert insights. Personalized for you.
The Japanese drugmaker has made cell therapy a focus, advancing three experimental cancer treatments into clinical testing with plans for two more MORE
202 
Manufacturing capacity is often decried as a major bottleneck in administering COVID-19 vaccines to a global population of 7.8 billion. For mRNA vaccines, the bottleneck is the availability of raw materials, not bioreactors MORE
The contract manufacturer aims to capitalize on progress for microbiome-based therapies, a field that's been buoyed by some recent clinical successes MORE
GSK will help manufacture up to 60 million doses of Novavaxâs COVID-19 vaccine from its facility at Barnard Castle in the UK, with doses to be distributed in the country. MORE
Twenty-twenty has demonstrated the need for a 24/7 , reliable manufacturing environment. Implement smart asset solutions to reduce COGs such as lean manufacturing and total productive maintenance. Events Partner Content pharma manufacturing MORE
The £20 million fund will boost the UK's life sciences manufacturing capabilities, creating new economic opportunities and highly skilled jobs MORE
Catalent, which is already helping the British pharma make its vaccine, will now add key services from a Maryland gene therapy plant MORE
The global professional services firm has signed on the newest partner in the collaboration, aimed toward promoting innovation in pharma manufacturing. Contract Manufacturing & Logistics MORE
Global Partner Research Organization Abzena will build a new GMP manufacturing facility in Sanford, North Carolina. Bio Developments MORE
The rollout of the US COVID-19 vaccination programme slowed up this week because manufacturing delays mean no new doses of the recently approved Johnson & Johnson vaccine are available. The post J&J manufacturing delays hit US vaccine rollout appeared first on. MORE
Abzena is opening another manufacturing site, its sixth in a global network. This morning, the partner research organization announced it would build a $200 million facility in Sanford, N.C. MORE
The Serum Institute, one of the world's largest vaccine producers, licensed Novavax's experimental shot, while Wockhardt signed on with the U.K. to help make AstraZeneca's candidate MORE
Integrated CRO/CDMO solutions for accelerated and more efficient early drug development programs MORE
Contract Manufacturing & LogisticsWhen growing market demand moved the Michigan CDMO to expand, it opted for a novel design-construction approach to building bigger digs. MORE
The post COVID-19 Stimulus Legislation Will Cost OTC Manufacturers appeared first on Camargo. Tucked away in the nearly 900 pages of the Coronavirus Aid, Relief, and Economic Security (CARES). MORE
113 Shortages Vaccination and Immunization Coronavirus (2019-nCoV) Factories and Manufacturing Drugs (Pharmaceuticals) Acquired Immune Deficiency SyndromeTwo decades ago, the U.S. launched a program to help supply the world with H.I.V. medication. It should take a similar approach to Covid. MORE
Pfizer becomes one of multiple external manufacturing organisations supporting scale-up of treatment MORE
A longer-than-expected timeline for developing a new manufacturing process means a key study for Axovant's top gene therapy likely won't begin until 2022 MORE
A leader from the pharma software solutions provider suggests streamlining communication between shifts can avoid manufacturing snags. Contract Manufacturing & Logistics MORE
ADVANTAGES OF THIRD PARTY MANUFACTURING IN PHARMA INDUSTRY. Amongst various business models used by people in the pharma manufacturing niche, third-party manufacturing is popular. Many people know that the third-party business model gives you a chance to manufacture the products even if you do not have adequate finance. The third-party pharma manufacturing model makes the whole process cost-effective. MORE
Telix Pharmaceuticals and Grand River Aseptic Manufacturing Complete Agreement for Commercial Manufacturing of Illuccix® Telix Pharmaceuticals and Grand River Aseptic Manufacturing Complete Agreement for Commercial Manufacturing of Illuccix® MELBOURNE, Australia and INDIANAPOLIS, March 30, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals … Continue reading → GlobeNewswire MORE
The U.S. is now averaging more than 2 million doses given each day, a pace that will help President Joe Biden meet his target of 100 million shots in 100 days well ahead of schedule MORE
Contract Manufacturing & LogisticsAccording to representatives from the pharma solutions provider, incorporation of CM processes, after a slow period, is expanding across the industry. MORE
Whether it was ordering meal kit boxes, having ready-made meals delivered or trying out niche direct-to-consumer (DTC) brands, smaller food manufacturers gave Big Food a run for its money — and they show no signs of slowing down. MORE
Louis van de Wiel, Vice President, Site Head EU Manufacturing, Kite, a Gilead Company, reveals the complexity that sits behind the process of individualised cell therapy – and why team culture makes it work. The post Why cell therapy manufacture is a team sport appeared first on. MORE
BioNTech will acquire Novartisâ GMP certified manufacturing facility in Marburg, Germany: with the site set to become one of the largest mRNA manufacturing plants in Europe. MORE
The two firms are joining forces to help life-sciences customers speed up adoption of continuous manufacturing in pharmaceutical processes. Contract Manufacturing & Logistics MORE
The agency has chosen Continuity Pharma to aid in development and advancement of continuous manufacturing technology, with the help of a $1.5m Contract Manufacturing & Logistics MORE
Solid Dosage Continuous Manufacturing Oral Solid Dosage ShapingTheFuture Syntegon Xelum MORE
A deal to fill vials of Pfizer and BioNTech's vaccine could be the first of several Novartis signs to help others make COVID-19 treatments MORE
Whether it was ordering meal kit boxes, having ready-made meals delivered or trying out niche direct-to-consumer (DTC) brands, smaller food manufacturers gave Big Food a run for its money — and they show no signs of slowing down. MORE
Though Alkermes believes it can quickly resolve the issues cited by the agency, the complete response letter nonetheless delays approval of a drug that's critical to the company's hopes of a turnaround MORE
Though it once had a glimmering manufacturing record, Mylan now finds itself in the crosshairs of the FDA. The agency is advising the company to quickly and comprehensively assess its global operations MORE
153 To achieve transparency and actionability of data, pharmaceutical companies are evolving their manufacturing processes by digitalizing the data from all of their equipment. Learn more by watching this webinar on-demand: CPV + AI: The Formula To Succeed In Biopharma Manufacturing. MORE
In 2019, Novartis subsidiary AveXis announced it acquired a manufacturing facility in Colorado to provide additional production capacity for Zolgensma. MORE
The New Jersey facility that ran afoul of FDA manufacturing standards is one of several Lilly is using to produce coronavirus antibody drugs MORE
For the past year, life science companies around the world worked at breakneck speed to develop and manufacture safe and effective treatments to respond to the COVID-19 pandemic. His experience spans sales & marketing, business development, R&D, manufacturing and operations. MORE
One vaccine batch being manufactured for J&J by Emergent Biosolutions failed quality checks, reportedly ruining material sufficient for up to 15 million doses MORE
The Novartis plant will help BioNTech and partner Pfizer make 750 million doses of their shot per year, and become one of the largest messenger RNA manufacturing sites in Europe MORE
The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines, including a COVID-19 treatment. Contract Manufacturing & Logistics MORE
The Serum Institute of India, a go-to partner for coronavirus vaccine makers, will help Novavax boost capacity to levels matching its larger rivals MORE
Incog BioPharma Services has become the latest entity to sprout up as part of a concerted U.S. effort to onshore production of pharmaceuticals MORE
Manufacturing Related Topics 
Bio Pharma Dive
APRIL 1, 2021
One vaccine batch being manufactured for J&J by Emergent Biosolutions failed quality checks, reportedly ruining material sufficient for up to 15 million doses
Bio Pharma Dive
SEPTEMBER 3, 2020
Though it once had a glimmering manufacturing record, Mylan now finds itself in the crosshairs of the FDA. The agency is advising the company to quickly and comprehensively assess its global operations
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Syntegon Technology Pharma Blog
OCTOBER 28, 2020
Solid Dosage Continuous Manufacturing Oral Solid Dosage ShapingTheFuture Syntegon Xelum
Bio Pharma Dive
OCTOBER 30, 2020
A longer-than-expected timeline for developing a new manufacturing process means a key study for Axovant's top gene therapy likely won't begin until 2022
Bio Pharma Dive
JANUARY 29, 2021
A deal to fill vials of Pfizer and BioNTech's vaccine could be the first of several Novartis signs to help others make COVID-19 treatments
Outsourcing Pharma
SEPTEMBER 21, 2020
A leader from the pharma software solutions provider suggests streamlining communication between shifts can avoid manufacturing snags. Contract Manufacturing & Logistics
Outsourcing Pharma
FEBRUARY 11, 2021
The global professional services firm has signed on the newest partner in the collaboration, aimed toward promoting innovation in pharma manufacturing. Contract Manufacturing & Logistics
Pharma Phorum
MARCH 22, 2021
For the past year, life science companies around the world worked at breakneck speed to develop and manufacture safe and effective treatments to respond to the COVID-19 pandemic. His experience spans sales & marketing, business development, R&D, manufacturing and operations.
Bio Pharma Dive
OCTOBER 22, 2020
The New Jersey facility that ran afoul of FDA manufacturing standards is one of several Lilly is using to produce coronavirus antibody drugs
Camargo
APRIL 2, 2020
The post COVID-19 Stimulus Legislation Will Cost OTC Manufacturers appeared first on Camargo. Tucked away in the nearly 900 pages of the Coronavirus Aid, Relief, and Economic Security (CARES).
Outsourcing Pharma
JANUARY 21, 2021
The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines, including a COVID-19 treatment. Contract Manufacturing & Logistics
Bio Pharma Dive
SEPTEMBER 15, 2020
The Japanese drugmaker has made cell therapy a focus, advancing three experimental cancer treatments into clinical testing with plans for two more
Bio Pharma Dive
AUGUST 26, 2020
Catalent, which is already helping the British pharma make its vaccine, will now add key services from a Maryland gene therapy plant
Pharma Phorum
JANUARY 6, 2021
Louis van de Wiel, Vice President, Site Head EU Manufacturing, Kite, a Gilead Company, reveals the complexity that sits behind the process of individualised cell therapy – and why team culture makes it work. The post Why cell therapy manufacture is a team sport appeared first on.
Syntegon Technology Pharma Blog
DECEMBER 1, 2020
Pharma Services Qualification/Validation
Bio Pharma Dive
SEPTEMBER 15, 2020
The Serum Institute of India, a go-to partner for coronavirus vaccine makers, will help Novavax boost capacity to levels matching its larger rivals
Bio Pharma Dive
MARCH 11, 2021
The U.S. is now averaging more than 2 million doses given each day, a pace that will help President Joe Biden meet his target of 100 million shots in 100 days well ahead of schedule
Bio Pharma Dive
NOVEMBER 17, 2020
Though Alkermes believes it can quickly resolve the issues cited by the agency, the complete response letter nonetheless delays approval of a drug that's critical to the company's hopes of a turnaround
BioSpace
NOVEMBER 24, 2020
Manufacturing capacity is often decried as a major bottleneck in administering COVID-19 vaccines to a global population of 7.8 billion. For mRNA vaccines, the bottleneck is the availability of raw materials, not bioreactors
Bio Pharma Dive
SEPTEMBER 17, 2020
The Novartis plant will help BioNTech and partner Pfizer make 750 million doses of their shot per year, and become one of the largest messenger RNA manufacturing sites in Europe
Bio Pharma Dive
SEPTEMBER 30, 2020
The contract manufacturer aims to capitalize on progress for microbiome-based therapies, a field that's been buoyed by some recent clinical successes
Pharma Phorum
MARCH 10, 2021
The rollout of the US COVID-19 vaccination programme slowed up this week because manufacturing delays mean no new doses of the recently approved Johnson & Johnson vaccine are available. The post J&J manufacturing delays hit US vaccine rollout appeared first on.
BioPharma Reporter
MARCH 30, 2021
GSK will help manufacture up to 60 million doses of Novavaxâs COVID-19 vaccine from its facility at Barnard Castle in the UK, with doses to be distributed in the country.
NY Times
JANUARY 12, 2021
Shortages Vaccination and Immunization Coronavirus (2019-nCoV) Factories and Manufacturing Drugs (Pharmaceuticals) Acquired Immune Deficiency SyndromeTwo decades ago, the U.S. launched a program to help supply the world with H.I.V. medication. It should take a similar approach to Covid.
Fossil Remedies
JULY 18, 2019
ADVANTAGES OF THIRD PARTY MANUFACTURING IN PHARMA INDUSTRY. Amongst various business models used by people in the pharma manufacturing niche, third-party manufacturing is popular. Many people know that the third-party business model gives you a chance to manufacture the products even if you do not have adequate finance. The third-party pharma manufacturing model makes the whole process cost-effective.
Pharma Times
APRIL 7, 2021
The £20 million fund will boost the UK's life sciences manufacturing capabilities, creating new economic opportunities and highly skilled jobs
Bio Pharma Dive
DECEMBER 7, 2020
Integrated CRO/CDMO solutions for accelerated and more efficient early drug development programs
BioSpace
APRIL 15, 2021
Abzena is opening another manufacturing site, its sixth in a global network. This morning, the partner research organization announced it would build a $200 million facility in Sanford, N.C.
Bio Pharma Dive
AUGUST 6, 2020
The Serum Institute, one of the world's largest vaccine producers, licensed Novavax's experimental shot, while Wockhardt signed on with the U.K. to help make AstraZeneca's candidate
BioTech 365
MARCH 30, 2021
Telix Pharmaceuticals and Grand River Aseptic Manufacturing Complete Agreement for Commercial Manufacturing of Illuccix® Telix Pharmaceuticals and Grand River Aseptic Manufacturing Complete Agreement for Commercial Manufacturing of Illuccix® MELBOURNE, Australia and INDIANAPOLIS, March 30, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals … Continue reading → GlobeNewswire
Pharma Times
OCTOBER 14, 2020
Company signs deals with two specialist pharmaceutical manufacturers
XTalks
OCTOBER 22, 2020
To achieve transparency and actionability of data, pharmaceutical companies are evolving their manufacturing processes by digitalizing the data from all of their equipment. Learn more by watching this webinar on-demand: CPV + AI: The Formula To Succeed In Biopharma Manufacturing.
BioPharma Reporter
SEPTEMBER 17, 2020
BioNTech will acquire Novartisâ GMP certified manufacturing facility in Marburg, Germany: with the site set to become one of the largest mRNA manufacturing plants in Europe.
Outsourcing Pharma
NOVEMBER 4, 2020
The two firms are joining forces to help life-sciences customers speed up adoption of continuous manufacturing in pharmaceutical processes. Contract Manufacturing & Logistics
BioSpace
MARCH 25, 2021
In 2019, Novartis subsidiary AveXis announced it acquired a manufacturing facility in Colorado to provide additional production capacity for Zolgensma.
BioPharma Reporter
APRIL 15, 2021
Global Partner Research Organization Abzena will build a new GMP manufacturing facility in Sanford, North Carolina. Bio Developments
Outsourcing Pharma
AUGUST 11, 2020
Contract Manufacturing & LogisticsWhen growing market demand moved the Michigan CDMO to expand, it opted for a novel design-construction approach to building bigger digs.
Outsourcing Pharma
NOVEMBER 4, 2020
Contract Manufacturing & LogisticsAccording to representatives from the pharma solutions provider, incorporation of CM processes, after a slow period, is expanding across the industry.
Pharma Phorum
JANUARY 15, 2021
Twenty-twenty has demonstrated the need for a 24/7 , reliable manufacturing environment. Implement smart asset solutions to reduce COGs such as lean manufacturing and total productive maintenance. Events Partner Content pharma manufacturing
XTalks
FEBRUARY 11, 2021
Whether it was ordering meal kit boxes, having ready-made meals delivered or trying out niche direct-to-consumer (DTC) brands, smaller food manufacturers gave Big Food a run for its money — and they show no signs of slowing down.
XTalks
FEBRUARY 11, 2021
Whether it was ordering meal kit boxes, having ready-made meals delivered or trying out niche direct-to-consumer (DTC) brands, smaller food manufacturers gave Big Food a run for its money — and they show no signs of slowing down.
Pharma Times
AUGUST 10, 2020
Pfizer becomes one of multiple external manufacturing organisations supporting scale-up of treatment
Bio Pharma Dive
OCTOBER 21, 2020
Incog BioPharma Services has become the latest entity to sprout up as part of a concerted U.S. effort to onshore production of pharmaceuticals
Let's personalize your content